Drug Profile
CS 8080
Alternative Names: CS-8080Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Daiichi Sankyo Company
- Class Vascular disorder therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arterial occlusive disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Arterial-occlusive-disorders(In volunteers) in USA (PO, Tablet)
- 31 Jan 2008 Phase-I clinical trials in Arterial occlusive disorders in USA (PO)